The National Association of State Controlled Substances Authorities (NASCSA) has received a $200,000 grant from Purdue Pharma LP, which it will distribute to state government agencies that are able to accept private funding specifically for their state prescription-monitoring programs. NASCSA will manage the solicitation, review, and funding of the grant proposals. Selection of recipients will be based on an independent review conducted by its Special Projects Committee, which consists of association members with expertise in the fields of prescription drug abuse and diversion, and prescription drug-monitoring programs. NASCSA expects to distribute the grants by the end of 2011. The grant is part of Purdue Pharma?s efforts to support the operation, expansion, and awareness of appropriately designed state prescription drug-monitoring programs.
The National Association of State Controlled Substances Authorities (NASCSA) has received a $200,000 grant from Purdue Pharma LP, which it will distribute to state government agencies that are able to accept private funding specifically for their state prescription-monitoring programs.
NASCSA will manage the solicitation, review, and funding of the grant proposals. Selection of recipients will be based on an independent review conducted by its Special Projects Committee, which consists of association members with expertise in the fields of prescription drug abuse and diversion, and prescription drug-monitoring programs. NASCSA expects to distribute the grants by the end of 2011.
The grant is part of Purdue Pharma’s efforts to support the operation, expansion, and awareness of appropriately designed state prescription drug-monitoring programs.
Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety
December 13th 2024A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.